Mary T Szela Insider Trading $KURA Kura Oncology, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mary T Szela.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mary T Szela. Mary T Szela is Senior Vice President in ABBOTT LABORATORIES ($ABT) and Chief Executive Officer in QLT INC/BC ($QLTI) and Director in ALIMERA SCIENCES INC ($ALIM) and Chief Executive Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Kura Oncology, Inc. ($KURA) and Director in Receptos, Inc. ($RCPT) and Director in Coherus BioSciences, Inc. ($CHRS) and Director in Prometheus Biosciences, Inc. ($RXDX).

Mary T Szela in Kura Oncology, Inc.

Trading Symbol: KURA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 26 2020
$KURA Market Capitalization: $124.74M
$KURA Previous Close: $6.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Mary T Szela in Kura Oncology, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ABT, AEGR, ALIM, CHRS, KURA, NVLN, RXDX, RCPT

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
Jun 26 2020	KURA	Kura Oncology, Inc ...	Szela Mary T	Director	Option Exercise	A	17.97	23,000	413,310	23,000
Jun 27 2019	KURA	Kura Oncology, Inc ...	Szela Mary T	Director	Option Exercise	A	19.55	13,000	254,150	13,000
Nov 08 2018	KURA	Kura Oncology, Inc ...	Szela Mary T	Director	Option Exercise	A	11.55	7,583	87,584	7,583
Nov 08 2018	KURA	Kura Oncology, Inc ...	Szela Mary T	Director	Option Exercise	A	11.55	30,000	346,500	30,000

Page: 1